Dissertações em Neurociências e Biologia Celular (Mestrado) - PPGNBC/ICB
URI Permanente para esta coleçãohttps://repositorio.ufpa.br/handle/2011/2375
O Mestrado Acadêmico pertence ao Programa de Pós-Graduação em Neurociências e Biologia Celular (PPGNBC) do Instituto de Ciências Biológicas (ICB) da Universidade Federal do Pará (UFPA).
Navegar
Navegando Dissertações em Neurociências e Biologia Celular (Mestrado) - PPGNBC/ICB por CNPq "CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA::ENZIMOLOGIA"
Agora exibindo 1 - 2 de 2
- Resultados por página
- Opções de Ordenação
Item Acesso aberto (Open Access) Análise da atividade enzimática de quitotriosidase como um marcador para a malária vivax: abordagens bioquímicas e moleculares(Universidade Federal do Pará, 2010) CRUZ, Cleber Monteiro; SILVA, Luiz Carlos Santana da; http://lattes.cnpq.br/6161491684526382Chitotriosidase was the first described chitinase and its physiologic role is not entirely clear, although many studies have been showed its participation as a component of human immune response. A 24pb duplication on exon 10 of chit1 gene results on RNAm frameshift, leading to a 87 nucleotides deletion. This alteration generates a protein with no catalytic activity at all. This condition is called chitotriosidase deficiency and presents a frequency close to 6% of homozygosis duplication in different ethnical groups. Malaria is an amazon endemic parasitosis caused by protozoaries of genus Plasmodium and causes symptoms as fever, headache and vomit, which leads to a characteristic immune response. The objective of this study was to evaluate the chitotriosidase enzyme behavior in patients suffering of malaria in Pará state and to determine the frequency of 24pb duplication on chitotriosidase gene in a representative sample. Chitotriosidase measurement was made in 100 healthy individual and in 47 malarial patients. The molecular analysis of the 24pb duplication was realized in 100 volunteers trough a protocol which included DNA extraction techniques, PCR and 2,5% agarose gel visualization to verify normal fragments (normal homozygote: 195pb) and the 24pb duplication (mutant homozygote: 219pb; heterozygote: 219pb e 195pb). This study described at first time on scientific literature the chitotriosidase plasmatic levels increasing in patients suffering of malaria vivax compared to healthy individual. No association was observed between parasitemia and plasmatic chitotriosidase levels in malarial patients. Molecular analysis showed a frequency of 72% normal homozygotes, 24% heterozygotes and 4% mutant homozygotes to 24pb duplication. Allelic frequencies were around 84% to wild allele and 16% to mutant allele. No correlation was found between genotype and biochemical phenotype (represented by chitotriosidase levels) on control group.Item Acesso aberto (Open Access) Cinética da enzima alfa-galactosidase a e investigação de doença de fabry em pacientes hemodialisados(Universidade Federal do Pará, 2011-11-01) ARAGÃO, Camila de Britto Pará de; SILVA, Luiz Carlos Santana da; http://lattes.cnpq.br/6161491684526382Human alpha-galactosidase A (α-Gal A) is a lysosomal enzyme which is deficient in Fabry disease. Fabry disease is a sphingolipidosis which chronic kidney failure (CKF) is the most important cause of morbidity and mortality. The aim of this study was the establishment of a laboratorial protocol that allows the diagnosis of Fabry’s disease in plasma and leukocytes, the analysis of α-Gal A kinetic features in plasma and searching for potential Fabry patients in 25 individual with unknown CKF. Reproducibility and fluorescence stability of the enzymatic method were also evaluated. The assay standardization was realized with the fluorescent substrate 4- methylumbeliferil-α-D-galactopyranoside. Reproducibility was evaluated using plasma samples stored at a 4ºC, -20ºC and -70ºC, the assay was performed once a month until 6 months and fluorescence stability was evaluated until 24 hours after the end of the assay. The standardization allowed the establishment of value references to α-Gal A in Pará State, from 4 to 28 nmoles/h/mL (plasma) and 20 to 96 nmoles/h/mg protein (leukocytes). α-Gal A enzyme was thermolabile and 1 minute of preincubation at 60ºC was sufficient to decrease 71.09% of its entire activity. The activity of the α-Gal A enzyme increased progressively according to incubation time, between 15 and 180 minutes. Its activity was better at pH 4,8, the Km value for the α-Gal A enzyme was 1.007 mM, and maximum reaction velocity was 30.9 nmoles/h/mL. The best storage temperature for plasma samples was -20ºC that showed less variation until 6 months. The enzyme method is stable and even after 24 hours, at room temperature, the fluorescence remained the same. All CKF patients with unknown cause presented α-Gal A activity between normal values, therefore neither was diagnosed with Fabry disease. Understanding the kinetics of the α-Gal A enzyme and its in vitro behavior will contribute to improvements in the laboratory diagnosis of Fabry disease, and provide a diagnostic baseline for the analysis of individuals affected by mutations in this enzyme.